Trademark Overview
On Saturday, January 18, 2025, a trademark application was filed for SYTELGY with the United States Patent and Trademark Office. The USPTO has given the SYTELGY trademark a serial number of 99012187. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Thursday, July 3, 2025. This trademark is owned by OCUGEN, INC.. The SYTELGY trademark is filed in the Pharmaceutical Products category with the following description:
Gene therapy products, namely, genetically engineered tissues for transplant purposes; Gene therapy products, namely, recombinant adeno-associated virus (rAAV) vector for treating ocular diseases; Gene therapy products, namely, recombinant adeno-associated virus (rAAV) vector for treating Retinitis Pigmentosa; Gene therapy products, namely, recombinant nucleic acid for treating ocular diseases; Gene therapy products, namely, recombinant nucleic acid for treating Retinitis Pigmentosa; Gene therapy products, namely, recombinant DNA for treating ocular diseases; Gene therapy products, namely, recombinant DNA for treating Retinitis Pigmentosa; Gene therapy products, namely, recombinant rAAV for treating ocular diseases such as Leber congenital amaurosis (LCA), retinitis pigmentosa, enhance S-cone syndrome, Goldmann Favre syndrome, rod-cone dystrophy Bardet-Biedl Syndrome, Achromatopsia, Best Disease (vitelliform macular degeneration), Bardet-Biedl Syndrome, Choroideremia, Macular Degenerat...
